Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma
R. Mercieca-Bebber, E. H. Barnes, K. Wilson, Z. Samoon, E. Walpole, T. Mai, S. Ackland, M. Burge, G. Dickie, D. Watson, J. Leung, T. Wang, R. Bohmer, D. Cameron, J. Simes, V. Gebski, M. Smithers, J. Thomas, J. Zalcberg, A. P. Barbour
Research output: Contribution to journal › Article › peer-review
1Citation
(Scopus)
42Downloads
(Pure)
Fingerprint
Dive into the research topics of 'Patient-reported outcome (PRO) results from the AGITG DOCTOR trial: a randomised phase 2 trial of tailored neoadjuvant therapy for resectable oesophageal adenocarcinoma'. Together they form a unique fingerprint.